Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens

Vaccine

Volumn 25, Issue 7, 2007, Pages 1204-1213

  Mutwiri, George ^a   Benjamin, Ponn ^a   Soita, Henry ^a   Townsend, Hugh ^a   Yost, Richard ^b   Roberts, Bryan ^b   Andrianov, Alexander K ^b   Babiuk, Lorne A ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b Parallel Solutions Inc   (United States)

Author keywords

Adjuvants; Polyphosphazene polyelectrolytes; Vaccines

Indexed keywords

ADJUVANT; BOVINE SERUM ALBUMIN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; INTERLEUKIN 4; NEUTRALIZING ANTIBODY; POLY[DI(SODIUM CARBOXYLATOETHYLPHENOXY)PHOSPHAZENE]; POLY[DI(SODIUM CARBOXYLATOPHENOXY)PHOSPHAZENE]; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN SPECIFICITY; AQUEOUS SOLUTION; ARTICLE; CHEMICAL STRUCTURE; CYTOKINE PRODUCTION; DRUG FORMULATION; ENZYME LINKED IMMUNOSPOT ASSAY; IMMUNE RESPONSE; IMMUNIZATION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERUM; SPLEEN CELL; TH1 CELL; TH2 CELL; VACCINE PRODUCTION; VIRUS NEUTRALIZATION;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; PHENYLPROPIONATES; POLYMERS; SERUM ALBUMIN, BOVINE; SPLEEN; TH1 CELLS; TH2 CELLS;

EID: 33845878818     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.10.011     Document Type: Article

References (20)

1. Ramon G. Ann Inst Pasteur 38 (1924) 1
2. Singh M., and O'Hagan D.T. Recent advances in vaccine adjuvants. Pharm Res 19 6 (2002) 715-728
3. Davis H.L., Weeratna R., Waldschmidt T.J., Tygrett L., Schorr J., and Krieg A.M. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol 160 2 (1998) 870-876
4. Merritt K., and Johnson A.G. Studies on the adjuvant action of bacterial endotoxins on antibody formation. VI. Enhancement of antibody formation by nucleic acids. J Immunol 94 (1965) 416-422
5. Schijns V.E. Antigen delivery systems and immunostimulation. Vet Immunol Immunopathol 87 3-4 (2002) 195-198
6. Westwood A., Elvin S.J., Healey G.D., Williamson E.D., and Eyles J.E. Immunological responses after immunisation of mice with microparticles containing antigen and single stranded RNA (polyuridylic acid). Vaccine (2005)
7. HogenEsch H. Mechanisms of stimulation of the immune response by aluminum adjuvants. Vaccine 20 Suppl. 3 (2002) S34-S39
8. Marshall B.C., and Adler S.P. Avidity maturation following immunization with two human cytomegalovirus (CMV) vaccines: a live attenuated vaccine (Towne) and a recombinant glycoprotein vaccine (gB/MF59). Viral Immunol 16 4 (2003) 491-500
9. Payne L.G., and Andrianov A.K. Protein release from polyphosphazene matrices. Adv Drug Deliv Rev 31 3 (1998) 185-196
10. Payne L.G., Jenkins S.A., Woods A.L., Grund E.M., Geribo W.E., Loebelenz J.R., et al. Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine. Vaccine 16 1 (1998) 92-98
11. McNeal M.M., Rae M.N., and Ward R.L. Effects of different adjuvants on rotavirus antibody responses and protection in mice following intramuscular immunization with inactivated rotavirus. Vaccine 17 11-12 (1999) 1573-1580
12. Wu J.Y., Wade W.F., and Taylor R.K. Evaluation of cholera vaccines formulated with toxin-coregulated pilin peptide plus polymer adjuvant in mice. Infect Immun 69 12 (2001) 7695-7702
13. Andrianov A.K., Svirkin Y.Y., and LeGolvan M.P. Synthesis and biologically relevant properties of polyhosphazene polyacids. Biomolecules 5 (2004) 1999-2006
14. O'Hagan D.T., MacKichan M.L., and Singh M. Recent developments in adjuvants for vaccines against infectious diseases. Biomol Eng 18 3 (2001) 69-85
15. Finkelman F.D., Holmes J., Katona I.M., Urban Jr. J.F., Beckmann M.P., Park L.S., et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 8 (1990) 303-333
16. Constant S.L., and Bottomly K. Induction of Th1 and Th2 CD4 + T cell responses: the alternative approaches. Annu Rev Immunol 15 (1997) 297-322
17. Yip H.C., Karulin A.Y., Tary-Lehmann M., Hesse M.D., Radeke H., Heeger P.S., et al. Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J Immunol 162 7 (1999) 3942-3949
18. Cribbs D.H., Ghochikyan A., Vasilevko V., Tran M., Petrushina I., Sadzikava N., et al. Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid. Int Immunol 15 4 (2003) 505-514
19. Mazumdar T., Anam K., and Ali N. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice. Vaccine 22 9-10 (2004) 1162-1171
20. Andrianov A.K., Marin A., and Roberts B.E. Polyphosphazene polyelectrolytes: a link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity. Biomacromolecules 6 3 (2005) 1375-1379